Trial intelligence / Profile preview

Magnesium Sulfate with Lidocaine for IANB in Pulpitis

NCT03262857Phase 2Completed

Start
Sep 2016
Primary completion
Sep 2018
Modality
Small Molecules
01

Overview

Phase 2, randomised, double-blind trial of magnesium sulfate in irreversible pulpitis (2 arms). Primary endpoints: Effect of Magnesium with lidocaine (Anesthesia Success) and Intensity of Pain. Started Sep 2016; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on NCT03262857.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03262857.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call